C. Dela Cruz (New Haven, United States of America), M. Si-Tahar (Tours, France), J. Rademacher (Hannover, Germany), G. Waterer (Perth (WA), Australia)
Three-dimensional lung epithelial cells potentiate aminoglycoside efficacy by enhancing intracellular pH in Pseudomonas aeruginosa
A. Crabbé (Ghent, Belgium), L. Ostyn (Ghent, Belgium), C. Rigauts (Ghent, Belgium), H. Van Acker (Ghent, Belgium), M. Risseeuw (Ghent, Belgium), S. Van Calenbergh (Ghent, Belgium), T. Coenye (Ghent, Belgium)
|  |
Characterization of murine model of chronic M. abscessus respiratory infection.
C. Riva (Milan, Italy), F. Gona (Milan, Italy), C. Cigana (Milan, Italy), M. Rossi (Milan, Italy), A. Esposito (Milan, Italy), T. Canu (Milan, Italy), A. Colarieti (Milan, Italy), A. Bragonzi (Milan, Italy), E. Tortoli (Milan, Italy), D. Cirillo (Milan, Italy)
| |
Dysregulation of lipid mediators in clinically stable bronchiectasis
P. Bedi (Edinburgh, United Kingdom), D. Davidson (Edinburgh, United Kingdom), B. Mchugh (Edinburgh, United Kingdom), A. Rossi (Edinburgh, United Kingdom), A. Hill (Edinburgh, United Kingdom)
| |
Suppressor of cytokine signalling 1 (SOCS1) and asthma exacerbations
K. Strong (London, United Kingdom), J. Zhu (London, United Kingdom), D. Jackson (London, United Kingdom), J. Dhariwal (London, United Kingdom), M. Trujillo-Torralbo (London, United Kingdom), S. Johnston (London, United Kingdom), M. Edwards (London, United Kingdom)
|  |
The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility
C. Vidaillac (Singapore, Singapore), V. Yong Lee (Singapore, Singapore), T. Kaur Jaggi (Singapore, Singapore), D. Roizman (Singapore, Singapore), J. Sankaran (Singapore, Singapore), T. Wohland (Singapore, Singapore), L. Yang (Singapore, Singapore), S. Chotirmall (Singapore, Singapore)
| |
Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections
E. Bodier-Montagutelli (Tours, France), J. Pardessus (Tours, France), E. Dalloneau (Tours, France), C. Fevre (Romainville, France), G. L'Hostis (Romainville, France), E. Morello (Tours, France), J. Gabard (Romainville, France), S. Le Guellec (Saint Etienne, France), R. Respaud (Tours, France), L. Vecellio (Tours, France), N. Heuzé-Vourc'H (Tours, France)
| |
Pseudomonas aeruginosa modulates the pulmonary immune response by affecting the IL17 / IL22 axis
R. GHINNAGOW (Paris, France), S. Kheir (Paris, France), B. Villeret (Paris, France), N. Serafini (Paris, France), I. Garcia-Verdugo (Paris, France), J. Sallenave (Paris, France)
| |
Trivalent Influenza Vaccine Responses in COPD
K. Staples (Southampton, United Kingdom), N. Williams (Southampton, United Kingdom), O. Bonduelle (Paris, France), A. Hutton (Paris, France), B. Combadière (Paris, France), T. Wilkinson (Southampton, United Kingdom)
| |
Amplified virus infection in a transforming growth factor-beta (TGFB) transgenic mouse model of inflammatory lung disease
B. Thomas (Melbourne, Australia), K. Kan-O (Fukuoka, Japan), H. Li (Melbourne, Australia), I. Simpson (Melbourne, Australia), J. Elias (Providence, United States of America), P. Bardin (Melbourne, Australia)
| |
Exhaled volatile markers analysed using Selected Ion Flow Tube Mass Spectrometry discriminate Pseudomonas aeruginosa and Streptococcus pneumoniae lung infection in a rat model study
G. Slingers (Hasselt, Belgium), P. Van Oort (Amsterdam, Netherlands), G. Koppen (Mol, Belgium), A. Maas (Amsterdam, Netherlands), J. Roelofs (Amsterdam, Netherlands), M. Schultz (Amsterdam, Netherlands), P. Jorens (Antwerp, Belgium), M. Raes (Hasselt, Belgium), L. Bos (Amsterdam, Netherlands)
| |
Inflammatory exacerbation and inadequate interferone response to RV1b infection in HDM-sensitized lung tissue
O. Danov (Hannover, Germany), L. Laßwitz (Hannover, Germany), H. Obernolte (Hannover, Germany), C. Hesse (Hannover, Germany), A. Braun (Hannover, Germany), S. Wronski (Hannover, Germany), K. Sewald (Hannover, Germany)
| |
Rapid in vitro detection of resistant strains by MCC-IMS
C. Steppert (Bayreuth, Germany), T. Dick (Bayreuth, Germany), I. Steppert (Leipzigayreuth, Germany), T. Bollinger (Bayreuth, Germany), G. Becher (Bernau, Germany)
| |
Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
S. Gandi (Edinburgh, United Kingdom), I. Cranston (Edinburgh, United Kingdom), G. Mclachlan (Edinburgh, United Kingdom), S. Wright (Edinburgh, United Kingdom), J. Baily (Edinburgh, United Kingdom), S. Stimpson (Saffron Walden, United Kingdom), S. Madden (Edinburgh, United Kingdom), M. Whitmarsh (Harlow, United Kingdom), A. Young (Harlow, United Kingdom), M. Mcelroy (Edinburgh, United Kingdom)
| |
Impact of enzymes and toxins potentiality of four Aspergillus species to cause aspergillosis
M. Adam (Assiut, Egypt), A. Zohri (Assiut, Egypt), B. Aboul-Nasr (Assiut, Egypt), E. Mahmoud Amer (Assiut, Egypt)
| |
Adaptation to oxidative stress induced-lung injury: friend or foe of influenza infection?
B. Allard (Montreal, Canada), E. Pernet (Montreal, Canada), J. Downey (Montreal, Canada), M. Divangahi (Montreal, Canada), J. Martin (Montreal, Canada)
| |
Exhaled breath analysis for the detection of Streptococcus pneumoniae and Pseudomonas aeruginosa lung infections using gas chromatography – mass spectrometry: a rat model study.
P. van Oort (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), G. Slingers (Hasselt, Belgium), G. Koppen (Mol, Belgium), A. Maas (Amsterdam, Netherlands), J. Roelofs (Amsterdam, Netherlands), R. Schnabel (Maastricht, Netherlands), D. Bergmans (Maastricht, Netherlands), R. Goodacre (Manchester, United Kingdom), S. Fowler (Manchester, United Kingdom), M. Schultz (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands)
| |
Mcyobacterium avium complex(MAC)-specific poly-functional CD8 T cells can discriminate MAC pulmonary disease from colonization
C. Shu (Taipei, Taiwan), P. Wang (New Taipei city, Taiwan)
| |
The medical tactics at repeated pneumonias.
N. Ponomareva (Russian Federation), M. Karakina (Ekaterinburg, Russian Federation)
| |
Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data
K. Bielosludtseva (Dnipro, Ukraine), M. Krykhtina (Dnipro, Ukraine), K. Dyagovets (Dnipro, Ukraine)
| |